CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Negative Risk Markers for Cardiovascular Events in the Elderly Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association Biological Versus Chronological Aging: JACC Focus Seminar Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research

Clinical Trial2021 Feb 16;143(7):673-684.

JOURNAL:Circulation. Article Link

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

TA Zelniker, M Ardissino, F Andreotti et al. Keywords: AF; AMI with atrial fibrillation and CHADS2 score ≥2; higher-dose edoxaban vs.lower-dose edoxaban regimen; warfarin; gender difference

Full Text PDF